Symbol="ENTA"
AssetType="Common Stock"
Name="Enanta Pharmaceuticals Inc"
Description="Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is headquartered in Watertown, Massachusetts."
CIK="1177648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="500 ARSENAL STREET, WATERTOWN, MA, US"
FiscalYearEnd="September"
LatestQuarter="2023-03-31"
MarketCapitalization="399406000"
EBITDA="-126630000"
PERatio="None"
PEGRatio="0"
BookValue="12.8"
DividendPerShare="0"
DividendYield="0"
EPS="-5.89"
RevenuePerShareTTM="3.901"
ProfitMargin="-1.536"
OperatingMarginTTM="-1.59"
ReturnOnAssetsTTM="-0.22"
ReturnOnEquityTTM="-0.397"
RevenueTTM="81176000"
GrossProfitTTM="86160000"
DilutedEPSTTM="-5.89"
QuarterlyEarningsGrowthYOY="-0.662"
QuarterlyRevenueGrowthYOY="-0.049"
AnalystTargetPrice="39.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.58"
PriceToBookRatio="2.88"
EVToRevenue="8.14"
EVToEBITDA="-5.8"
Beta="0.382"
num_52WeekHigh="76.36"
num_52WeekLow="18.24"
num_50DayMovingAverage="23.1"
num_200DayMovingAverage="39.42"
SharesOutstanding="21055400"
DividendDate="None"
ExDividendDate="None"
symbol="ENTA"
open="18.73"
high="18.89"
low="18.24"
price="18.80"
volume="171091.00"
latest_trading_day="2023-07-21"
previous_close="18.66"
change="0.14"
change_percent="0.7503%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="86"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="14"
Volume_recent_avg="213393"
Change_recent_avg="-0.21"
Delta_recent_avg="1.39"
Variance_recent_avg="0.69"
Change_ratio_recent_avg="-0.68"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="14"
Aroon_momentum_negative="86"
image_negative_thumbnail_id_1="1103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="559"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="656"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_positive_thumbnail_id_2="651"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0057.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
